EDIT:NASDAQ
Editas Medicine Inc
2,17 $
arrow_upward
+1,40%(+0,030) 1D
2,18 $
arrow_upward
+0,46% (+0,0100)todayPre-market
Closed: 13 նոյ, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
2,14 $
High
2,21 $
Low
2,01 $
Mkt. cap
334,92 մլն
Avg. vol.
2,42 մլն
Volume
3,58 հզր
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
Open
2,14 $
High
2,21 $
Low
2,01 $
Mkt. cap
334,92 մլն
Avg. vol.
2,42 մլն
Volume
3,58 հզր
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
News stories
From web sources and news partners
Opening Bell Daily
·
7 րոպե առաջ
Berkshire stock: beat the S&P 500 in every dot-com bust year
The Lufkin Daily News
·
27 րոպե առաջ
S&P 500, Nasdaq futures fall ahead of Nvidia earnings, Anthropic IPO
Barron's
·
28 րոպե առաջ
S&P 500 Futures Fall in Premarket Trading; TELUS Corp., Vaxcyte Lead
Benzinga
·
52 րոպե առաջ
12 Industrials Stocks Moving In Monday's Pre-Market Session
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc